Latest News and Press Releases

GUANGZHOU, China, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI-driven Internet healthcare solutions, received prominent...

The XS LLM integrates five intelligent agents into a closed-loop system covering the full chronic disease management cycle.

ROCKVILLE, Md. and SUZHOU, China, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company, a global, commercial stage,...

ICP-538 is the first VAV1 degrader approved to enter clinical trials in China and the second globally.

Fangzhou Wins Tencent Health ‘AI-Powered Future Award’ as MaaS Platform Drives AI Chronic Care.

סן פרנסיסקו וגואנגג'ואו, סין, Feb. 06, 2026 (GLOBE NEWSWIRE) -- WeRide (HKEX: 0800.HK , נאסד"ק: WRD), מובילה עולמית בטכנולוגיית נהיגה אוטונומית, ו- Uber Technologies, Inc (אובר, NYSE:...

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Feb. 06, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM: HCM; SEHK:13) will be announcing its final results for the year...

WeRide and Uber will deploy at least 1,200 Robotaxis across the Middle East, with deployment expected to be completed as soon as 2027.

ROCKVILLE, Md. and SUZHOU, China, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical company...

HONG KONG, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Kuaishou Technology ("Kuaishou" or the "Company"; HKD Counter Stock Code: 01024 / RMB Counter Stock Code: 81024), a leading content community and social...